Biotalys NV Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Biotalys NV stock has a consensus rating of "Buy" and an average price target of €5.03. The average 1-year stock price forecast is 62.26% higher than the current stock price, while the lowest is €3.40 (+9.68%) and the highest is €6.00 (+93.55%).

Price Target: €5.03 (+62.26%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	€3.40	€5.03	€5.70	€6.00
Change	+9.68%	+62.26%	+83.87%	+93.55%

Analyst Ratings

The average analyst rating for Biotalys NV stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	2	2	2	2	2
Buy	0	1	0	0	0	0
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	2	2	3	3

Financial Forecast

Revenue This Year

13.24M

Revenue Next Year

16.69M

from 13.24M

26.10%

from 13.24M

EPS This Year

-0.43

from -0.42

EPS Next Year

-0.29

from -0.43

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	13.24M
Operating Income	-17.58M	-22.53M	-20.89M	-13.49M	-15.84M	-7.09M
Net Income	-16.93M	-22.73M	-20.51M	-13.19M	-15.76M	-17.70M
EPS	-	-	-	-	-0.42	-0.43
Free Cash Flow	-14.26M	-11.70M	-10.95M	-7.15M	-7.38M	-19.50M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	13.2M
Avg	13.2M
Low	13.2M

Revenue Growth

Revenue Growth	2027	2028
High	26.1%
Avg	26.1%
Low	26.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.43
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-